Roman Butler Fullerton & Co. Cuts Stock Holdings in UnitedHealth Group Incorporated (NYSE:UNH)

Roman Butler Fullerton & Co. trimmed its stake in shares of UnitedHealth Group Incorporated (NYSE:UNH) by 24.6% in the 4th quarter, according to its most recent disclosure with the SEC. The institutional investor owned 1,140 shares of the healthcare conglomerate’s stock after selling 372 shares during the period. Roman Butler Fullerton & Co.’s holdings in UnitedHealth Group were worth $573,000 at the end of the most recent quarter.

Several other institutional investors also recently bought and sold shares of the stock. Moneta Group Investment Advisors LLC grew its stake in shares of UnitedHealth Group by 100,076.4% in the 4th quarter. Moneta Group Investment Advisors LLC now owns 11,823,820 shares of the healthcare conglomerate’s stock worth $6,268,753,000 after buying an additional 11,812,017 shares in the last quarter. Norges Bank purchased a new position in shares of UnitedHealth Group during the 4th quarter worth about $5,210,004,000. Arrowstreet Capital Limited Partnership boosted its stake in shares of UnitedHealth Group by 1,682.4% during the 1st quarter. Arrowstreet Capital Limited Partnership now owns 2,691,542 shares of the healthcare conglomerate’s stock worth $1,372,606,000 after purchasing an additional 2,540,538 shares during the period. International Assets Investment Management LLC boosted its stake in shares of UnitedHealth Group by 53,573.1% during the 4th quarter. International Assets Investment Management LLC now owns 2,352,490 shares of the healthcare conglomerate’s stock worth $1,238,515,000 after purchasing an additional 2,348,107 shares during the period. Finally, Barclays PLC boosted its stake in shares of UnitedHealth Group by 143.4% during the 2nd quarter. Barclays PLC now owns 3,494,100 shares of the healthcare conglomerate’s stock worth $1,679,401,000 after purchasing an additional 2,058,829 shares during the period. 87.86% of the stock is owned by hedge funds and other institutional investors.

Insider Activity at UnitedHealth Group

In related news, CAO Thomas E. Roos sold 858 shares of the company’s stock in a transaction on Friday, February 23rd. The shares were sold at an average price of $525.79, for a total value of $451,127.82. Following the completion of the sale, the chief accounting officer now owns 32,289 shares in the company, valued at approximately $16,977,233.31. The transaction was disclosed in a legal filing with the SEC, which can be accessed through the SEC website. In other news, EVP Erin Mcsweeney sold 1,236 shares of the company’s stock in a transaction on Friday, March 8th. The shares were sold at an average price of $483.48, for a total transaction of $597,581.28. Following the transaction, the executive vice president now directly owns 9,364 shares of the company’s stock, valued at approximately $4,527,306.72. The transaction was disclosed in a filing with the SEC, which is accessible through the SEC website. Also, CAO Thomas E. Roos sold 858 shares of the company’s stock in a transaction on Friday, February 23rd. The stock was sold at an average price of $525.79, for a total transaction of $451,127.82. Following the transaction, the chief accounting officer now directly owns 32,289 shares in the company, valued at $16,977,233.31. The disclosure for this sale can be found here. 0.35% of the stock is owned by insiders.

UnitedHealth Group Stock Performance

UNH opened at $493.16 on Friday. The firm’s fifty day simple moving average is $488.97 and its two-hundred day simple moving average is $515.22. The company has a quick ratio of 0.79, a current ratio of 0.85 and a debt-to-equity ratio of 0.69. The company has a market cap of $454.66 billion, a price-to-earnings ratio of 30.14, a PEG ratio of 1.31 and a beta of 0.54. UnitedHealth Group Incorporated has a 52-week low of $436.38 and a 52-week high of $554.70.

UnitedHealth Group (NYSE:UNH) last issued its quarterly earnings results on Tuesday, April 16th. The healthcare conglomerate reported $6.91 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $6.63 by $0.28. The company had revenue of $99.80 billion during the quarter, compared to the consensus estimate of $99.23 billion. UnitedHealth Group had a net margin of 4.05% and a return on equity of 26.50%. The firm’s quarterly revenue was up 8.6% on a year-over-year basis. During the same quarter in the previous year, the firm earned $6.26 earnings per share. Equities analysts anticipate that UnitedHealth Group Incorporated will post 27.74 earnings per share for the current fiscal year.

UnitedHealth Group Dividend Announcement

The firm also recently declared a quarterly dividend, which was paid on Tuesday, March 19th. Investors of record on Monday, March 11th were given a $1.88 dividend. The ex-dividend date was Friday, March 8th. This represents a $7.52 annualized dividend and a yield of 1.52%. UnitedHealth Group’s dividend payout ratio (DPR) is 45.97%.

Analysts Set New Price Targets

UNH has been the subject of a number of research analyst reports. StockNews.com lowered shares of UnitedHealth Group from a “buy” rating to a “hold” rating in a report on Thursday. Oppenheimer reiterated an “outperform” rating and set a $610.00 price objective on shares of UnitedHealth Group in a report on Wednesday, January 17th. Truist Financial reiterated a “buy” rating and set a $600.00 price objective on shares of UnitedHealth Group in a report on Wednesday. Erste Group Bank restated a “hold” rating on shares of UnitedHealth Group in a report on Wednesday, March 13th. Finally, Piper Sandler boosted their price target on shares of UnitedHealth Group from $566.00 to $571.00 and gave the company an “overweight” rating in a report on Wednesday. Four equities research analysts have rated the stock with a hold rating and fourteen have given a buy rating to the company. Based on data from MarketBeat, the company presently has a consensus rating of “Moderate Buy” and an average price target of $569.68.

About UnitedHealth Group

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.